Large Cap High Growth Potential

Results

254

5 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

254 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	NVDA	US$195.74	-7.1%	26.3%	US$4.8t	US$298.93	29.7	21.8%	0.5%	Semiconductors
	CRDO	US$268.03	-1.4%	182.0%	US$50.2b	US$269.81	105.8	27.5%	n/a	Semiconductors
	MDGL	US$513.79	1.6%	71.5%	US$11.8b	US$678.71	10.5	59.2%	n/a	Pharmaceuticals & Biotech
	LITE	US$861.97	1.4%	810.1%	US$65.5b	US$1,111.29	152.8	79.1%	n/a	Tech
	MOD	US$283.67	-4.6%	178.8%	US$14.6b	US$340.86	123.3	49.3%	n/a	Capital Goods
	GH	US$142.94	8.5%	185.7%	US$18.2b	US$143.09	17.5	58.5%	n/a	Healthcare
	AXSM	US$237.33	-5.3%	131.4%	US$12.2b	US$276.47	17.2	57.4%	n/a	Pharmaceuticals & Biotech
	CIFR	US$25.68	-12.0%	512.9%	US$10.7b	US$32.63	50.1	86.8%	n/a	Software
	NU	US$12.46	-2.0%	-6.9%	US$60.6b	US$17.86	4.8	20.2%	n/a	Banks
	SMTC	US$162.27	2.6%	255.7%	US$14.8b	US$205.25	13.9	74.6%	n/a	Semiconductors
	ARM	US$347.71	-20.9%	119.9%	US$383.5b	US$295.95	410.8	35.6%	n/a	Semiconductors
	AMD	US$532.57	-0.9%	270.7%	US$847.5b	US$500.40	176.1	35.1%	n/a	Semiconductors
	BE	US$309.18	-6.0%	1,284.6%	US$92.8b	US$266.93	14577.2	44.9%	n/a	Capital Goods
	MRVL	US$281.26	-9.4%	251.7%	US$242.1b	US$242.50	97.4	25.7%	0.09%	Semiconductors
	FN	US$567.79	-1.0%	89.9%	US$20.4b	US$749.11	48.3	23.3%	n/a	Tech
	MTSI	US$390.19	-0.3%	174.3%	US$28.5b	US$403.00	168.4	39.3%	n/a	Semiconductors
	CBRS	US$168.52	-28.2%	n/a	US$40.0b	US$299.30	378.7	91.7%	n/a	Semiconductors
	AVGO	US$378.91	-7.9%	40.2%	US$1.8t	US$523.73	61.5	33.5%	0.7%	Semiconductors
	ALAB	US$398.00	-4.6%	306.3%	US$68.5b	US$263.60	254.9	29.4%	n/a	Semiconductors
	AXON	US$444.73	5.0%	-44.7%	US$36.8b	US$662.04	174.0	32.8%	n/a	Capital Goods
	RDDT	US$158.02	-9.7%	9.8%	US$30.9b	US$224.92	43.0	25.3%	n/a	Media
	LSCC	US$144.20	-6.2%	185.5%	US$19.7b	US$146.92	993.8	59.3%	n/a	Semiconductors
	APP	US$445.93	-5.1%	28.3%	US$156.2b	US$650.30	38.3	22.0%	n/a	Software
	KRYS	US$359.93	3.4%	152.4%	US$10.2b	US$349.78	47.2	36.6%	n/a	Pharmaceuticals & Biotech

Page 1 of 8